A reliable diagnostic system that is scientifically sound, digitally connected, and publicly accountable is essential for better outcomes and stronger public trust ...

Despite seeing encouraging results, the New Brunswick woman says she doesn't qualify for a program that helps pay for food ...

BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.

WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

I would have gone down that road,” says a Carpenders Park woman with terminal cancer speaking out against the assisted dying bill.

Kate Martin, the former college teammate of Caitlin Clark turned WNBA guard, is having a solid 2025 season. The 6-foot, ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

The shares of this leading pharmaceutical company are in focus after the company secured the USFDA's approval for its key ...

BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription Rights") ...

BerGenBio ASA (OSE: BGBIO) ("BerGenBio" or the "Company") and Oncoinvent ASA (OSE: ONCIN) ("Oncoinvent") announce that they have entered into a merger agreement (the "Agreement") to combine the two ...

BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription Rights") for the Company's existing shareholders at the time ...